ArticleVaccines2023

Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization.

Wolfgang Schönharting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.